Lv767
3585 积分 2020-09-07 加入
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
18天前
已完结
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
18天前
已完结
抗肿瘤药物相关间质性肺病诊治专家共识
1个月前
已完结
非小细胞肺癌MET临床检测中国专家共识
2个月前
已完结
EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer
3个月前
已完结
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
3个月前
已完结
Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: End of the Road or the First Chapter?
3个月前
已完结
Outpatient burn management
3个月前
已完结
OUTPATIENT BURN MANAGEMENT
3个月前
已关闭
Ⅱ度烧伤创面治疗专家共识（2024版）Ⅱ：手术治疗和感染防治
3个月前
已完结
皖公网安备34019202002308
